SCHEMBL4735381

SCHEMBL4735381

Cc1ccncc1-c1ccc2nc(Nc3ccc(C(=O)NCCCN(C)C)cc3)ncc2c1

nearest known ligand 0.78

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ BRAF P15056 20/20 0.78
▸ RAF1 P04049 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4736963 0.86 BRAF (0.68) BRAFRAF1
SCHEMBL5128098 0.82 BRAF (0.79) BRAFRAF1
SCHEMBL3042504 0.79 BRAF (0.78) BRAFRAF1
SCHEMBL4735339 0.79 BRAF (0.58) BRAF
SCHEMBL4736008 0.78 BRAF (0.62) BRAFRAF1
SCHEMBL3041272 0.78 BRAF (0.72) BRAFRAF1
SCHEMBL4738322 0.77 BRAF (0.62) BRAFRAF1
SCHEMBL3034254 0.77 BRAF (1.00) BRAFRAF1
SCHEMBL14569081 0.72 ABL1 (0.58) BRAF
SCHEMBL4885707 0.72 BRAF (0.83) BRAFRAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008068507-A2 2 -PHENYLAMINO, 6- (PYRID-3-YL) QUINAZOLINE DERIVATIVES AS RAF-PROTEIN KINASE INHIBITORS IN CANCER TREATMENT ASTRAZENECA AB (SE) 2008-06-12 — — WO claimed
Send feedback